Long-Term Effect of Interferon Therapy in Patients with HBeAg Positive Chronic Hepatitis B Infection

Senturk, Hakan; Baysal, Birol; Tahan, Veysel; Zerdali, Hasan; Ozaras, Reşat; Tabak, Ömer; Mert, Ali; Canbakan, Billur; Tabak, Ömür; Ozbay, Gulsen

doi:10.1007/s10620-010-1255-9

Long-Term Effect of Interferon Therapy in Patients with HBeAg Positive Chronic Hepatitis B Infection

Senturk H., Baysal B., Tahan V., Zerdali H., Ozaras R., Tabak F., ...Daha Fazla

DIGESTIVE DISEASES AND SCIENCES, cilt.56, sa.1, ss.208-212, 2011 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 56 Sayı: 1
Basım Tarihi: 2011
Doi Numarası: 10.1007/s10620-010-1255-9
Dergi Adı: DIGESTIVE DISEASES AND SCIENCES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.208-212
İstanbul Üniversitesi Adresli: Evet

Özet

Introduction Several studies have reported that interferon therapy increases elimination rate of HBeAg and anti-HBe seroconversion in chronic hepatitis B (CHB) patients. We aimed to evaluate long-term results of interferon-alpha treatment in HBeAg positive CHB patients in a country with exclusively D genotype.